buy sell hold 



NanoFilm Technologies International (NANO SP)

Conference Call Takeaways; Expect Further Re-rating


We recently hosted a conference call with NanoFilm’s CFO. The key takeaways are: a) FCVA technology opens up opportunities in new markets; b) growth would be driven by larger wallet share and organic growth; and c) growth in medium term will be supported by additional capacity from second Shanghai plant. Further improvement in profitability and wider analyst coverage should help NanoFilm re-rate upwards. We maintain BUY and raise our target price by 11% to S$4.52.


Read More ...



Top Glove Corporation

Undervalued at current prices


■ We deem 1QFY8/21 net profit of RM2.6bn (+2,198% yoy) to be in-line at 24.7% of our FY21F estimate but above Bloomberg consensus.

■ TOPG should record stronger results in quarters ahead, backed by: i) higher ASPs, ii) increase in production capacity, and iii) higher economies of scale.

■ We reiterate our Add call with a lower TP of RM8.90 (16x CY22 P/E).


Read More ...



ASEAN Macro Year Ahead: 2021 Recovery & Reopening


2021: Recovery and Reopening After the worst recession since the Great Depression, the global economy is on track for a healthy recovery. We forecast global real GDP rebounding by +5.1% in 2021 after contracting by 4% in 2020. A Covid vaccine has sparked optimism, but the rollout and impact will be uneven across the world. Global monetary conditions will remain accommodative, underpinned by near zero interest rates and QE polices in the advanced economies.


Read More ...




ROE Firmly On Road To Recovery; Keep BUY


Maintain BUY, new SGD30.00 TP from SGD25.20, 18% upside with 3.5% FY21F yield. We believe DBS is on its way to a sustained ROE recovery in FY21-22F. Aside from lower credit costs, the pick-up in economic activities will underpin continued improvements in fee income growth and loan demand. Strategies to manage excess liquidity and deposit repricing should also help support NII. The acceleration in digital adoption, spurred by COVID-19, also places DBS ahead of peers. At 1.05x FY21F P/BV against ROE of 9.5%, the current valuation remains compelling.


Read More ...



LionelLim8.16Check out our compilation of Target Prices

You may also be interested in:

You have no rights to post comments

Counter NameLastChange
AEM Holdings3.280-0.020
Avi-Tech Electronics0.250-0.005
Best World1.680-
Broadway Ind0.0920.002
China Sunsine0.3950.005
Delfi Limited1.1500.030
Food Empire1.1000.010
Fortress Minerals0.290-0.010
Geo Energy Res0.275-0.005
GSS Energy0.028-
Hong Leong Finance2.4900.020
Hongkong Land (USD)3.190-
ISDN Holdings0.330-0.005
IX Biopharma0.043-
Jiutian Chemical0.025-
KSH Holdings0.290-
Leader Env0.0530.003
Medtecs Intl0.1410.005
Nordic Group0.400-
Oxley Holdings0.099-0.001
REX International0.167-0.001
Sinostar PEC0.135-
Southern Alliance Mining0.670-0.005
Straco Corp.0.470-0.015
Sunpower Group0.240-
The Trendlines0.0910.001
Totm Technologies0.038-
Uni-Asia Group0.905-0.030
Wilmar Intl3.610-
Yangzijiang Shipbldg1.5000.050

We have 695 guests and no members online

rss_2 NextInsight - Latest News